Finnålsaspirationscytologi ved mammografiscreening
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Finnålsaspirationscytologi ved mammografiscreening. / Engvad, Birte; Laenkholm, Anne-Vibeke; Schwartz, Walter; Bak, Martin.
In: Ugeskrift for Laeger, Vol. 171, No. 34, 17.08.2009, p. 2379-82.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Finnålsaspirationscytologi ved mammografiscreening
AU - Engvad, Birte
AU - Laenkholm, Anne-Vibeke
AU - Schwartz, Walter
AU - Bak, Martin
PY - 2009/8/17
Y1 - 2009/8/17
N2 - INTRODUCTION: In the year 2000 a quality assurance programme for the preoperative breast diagnostics was introduced in Denmark. The programme was based on the "European guidelines for quality assurance in breast cancer screening and diagnosis" where - among other measures - five cytological diagnostic classes were introduced. The aim of this study was to evaluate the quality assurance programme in a screening population to determine whether fine needle aspiration cytology (FNAC) as first choice remains a useful tool in the preoperative diagnostics, or if needle core biopsy should be the first-choice treatment.MATERIAL AND METHODS: 767 women had FNAC performed from a total of 783 lesions at the Mammography Clinic, University Hospital Odense. All FNACs were compared with the final histology diagnosis. Nine statistical parameters were calculated according to the European guidelines.RESULTS: A total of 66% of the 783 FNACs had a malignant cytology diagnosis, which in 99% of the cases turned out to be the correct diagnosis. Four lesions were false positives all of which represented benign proliferative breast diseases. The surgical procedures in these cases were either excisional biopsy or lumpectomy. The values of eight of the nine mutually dependent statistical parameters of quality scored within the recommended threshold values. Specificity was the only parameter that fell outside the recommended threshold values.CONCLUSION: Although specificity in our study is lower than recommended, we find that the use of FNAC as first-choice in triple diagnostics is a useful tool.
AB - INTRODUCTION: In the year 2000 a quality assurance programme for the preoperative breast diagnostics was introduced in Denmark. The programme was based on the "European guidelines for quality assurance in breast cancer screening and diagnosis" where - among other measures - five cytological diagnostic classes were introduced. The aim of this study was to evaluate the quality assurance programme in a screening population to determine whether fine needle aspiration cytology (FNAC) as first choice remains a useful tool in the preoperative diagnostics, or if needle core biopsy should be the first-choice treatment.MATERIAL AND METHODS: 767 women had FNAC performed from a total of 783 lesions at the Mammography Clinic, University Hospital Odense. All FNACs were compared with the final histology diagnosis. Nine statistical parameters were calculated according to the European guidelines.RESULTS: A total of 66% of the 783 FNACs had a malignant cytology diagnosis, which in 99% of the cases turned out to be the correct diagnosis. Four lesions were false positives all of which represented benign proliferative breast diseases. The surgical procedures in these cases were either excisional biopsy or lumpectomy. The values of eight of the nine mutually dependent statistical parameters of quality scored within the recommended threshold values. Specificity was the only parameter that fell outside the recommended threshold values.CONCLUSION: Although specificity in our study is lower than recommended, we find that the use of FNAC as first-choice in triple diagnostics is a useful tool.
KW - Biopsy, Fine-Needle/standards
KW - Breast Neoplasms/diagnosis
KW - False Negative Reactions
KW - False Positive Reactions
KW - Female
KW - Humans
KW - Mammography/standards
KW - Mass Screening/standards
KW - Quality Assurance, Health Care
KW - Sensitivity and Specificity
M3 - Tidsskriftartikel
C2 - 19732519
VL - 171
SP - 2379
EP - 2382
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 34
ER -
ID: 259932426